Quick Answer
COGNITION THERAPEUTICS INC reported Net Income Loss of -$23.49 million for the year ending 2025.
- COGNITION THERAPEUTICS INC showed an increase of +30.9% in Net Income Loss from 2024 to 2025.
- This data is from COGNITION THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), COGNITION THERAPEUTICS INC's Net Income Loss has declined by 199.6%.
- Historical annual values: Fiscal year 2025: -$23.49 million | Fiscal year 2024: -$33.97 million | Fiscal year 2023: -$25.79 million | Fiscal year 2022: -$21.40 million | Fiscal year 2021: -$11.72 million | Fiscal year 2020: -$7.84 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: